Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Silexion Therapeutics Corp (SLXN) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Silexion Therapeutics Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 2022416.
Total stock buying since 2026: $0.
Total stock sales since 2026: $31,032.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 22,818 | $31,032 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-03 | 0 | $0 | 22,818 | $31,032 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-26 | Shirvan Mitchell (CSO and CDO) | Sale | 22,818 | 1.36 | 31,032 |
Insider trading activities including stock purchases, stock sales, and option exercises of SLXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Silexion Therapeutics Corp (symbol SLXN, CIK number 2022416) see the Securities and Exchange Commission (SEC) website.